PARP1 and neoplasm: The utilization of PARP-1-targeting probes to detect PARP-1 expression in tumor cells has potential value for identifying patient populations suitable for PARPi-targeted therapy and improving treatment efficacy (Dibitetto et al., 2024; Bhin et al., 2023; Wang et al., 2019).